March 10, 2026
Corp Fin Updates Rule 701 and Other Compliance and Disclosure Interpretations
As Meredith recently noted on The Advisor’s Blog on CompensationStandards.com, last Friday the Corp Fin Staff updated the Compliance and Disclosure Interpretations addressing Securities Act Rule 701, which exempts offers and sales of securities pursuant to a compensatory benefit plan by a private company to employees, directors, officers, consultants, advisers, and other individuals providing bona fide services to the company. Here are the updates to the relevant Securities Act Rules CDIs:
New Question 271.26 clarifies when companies must provide disclosure under Rule 701(e)(1)–(6) if the aggregate sales price of securities sold under this exemption during a consecutive 12-month period exceeds $10 million.
New Question 271.27 states that the Rule 701 exemption is lost for the entire offering during the 12-month period in which the $10 million threshold is exceeded if the issuer fails to provide the required Rule 701(e) disclosure within a reasonable period before the date of sale.
Revised Questions 271.10, 271.12, 271.14, 271.16, 271.23 and 271.24 are updated solely to replace outdated references to $5 million with $10 million (which was updated in Rule 701(e) in 2018).
Other CDI updates from this batch address a number of other non-Rule 701 topics, including an updated CDI that addresses the definition of “ineligible issuer” (Securities Act Rules CDI Question 203.03 (redline)). A new CDI confirms that a new CIK is not required following a reorganization (Securities Act Forms CDI Question 101.06), and another new CDI indicates that the failure to check the SRC status box does not result in loss of SRC status or the ability to use SRC accommodations (Regulation S-K CDI Question 102.06).
– Dave Lynn
Blog Preferences: Subscribe, unsubscribe, or change the frequency of email notifications for this blog.
UPDATE EMAIL PREFERENCESTry Out The Full Member Experience: Not a member of TheCorporateCounsel.net? Start a free trial to explore the benefits of membership.
START MY FREE TRIAL